HOME >> MEDICINE >> NEWS
Health initiatives can help peace building in the Middle East

An article published online by THE LANCET today (Tuesday January 25, 2005) describes how health initiatives have led to Arab and Israeli cooperation in the Middle East.

Harvey Skinner (University of Toronto, Canada) and colleagues outline the work of the Canada International Scientific Exchange Program (CISEPO), which has successfully fostered collaborative work in the region involving Israeli, Jordanian and Palestinian health professionals since 1995.

In its first initiative CISEPO identified hearing loss as an important health issue for the region and helped broker the creation of the Middle East Association for Managing Hearing Loss (MEHA) the first joint Arab and Israeli professional association.

The cross-border project led to Palestinian and Israeli basic science research programmes between Bethlehem University and Tel Aviv University in the genetics of hearing loss, and generated joint-publications. From this followed a project to screen and habilitate 17,000 Israeli, Jordanian and Palestinian newborns for hearing loss.

CISEPO has now expanded from its initial focus on congenital hearing loss to include activities on health of mothers and children, promotion of health in young people, nutrition and infectious diseases. Overlapping components of these projects include co-authorship of presentation and papers, joint research meetings, international exchanges and training, visiting scholars, fellowships, continuing education, and electronic distance learning.

Professor Skinner comments: "Concern is mounting about our ability to address global health issues in the 21st century in a climate of national, ethnocultural, and religious conflicts. The Middle East, in particular, presents immense challenges for improving regional disparities in health and fostering peaceful coexistence.

"Our work has shown that it is possible to bring Arabs and Israelis together to achieve common goals under very difficult circumstanc
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
25-Jan-2005


Page: 1 2

Related medicine news :

1. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
2. Liverpool to lead 20M Department of Health initiative to develop medicines for children
3. Health care report cards may increase racial/ethnic disparities in bypass operations
4. 2005 Behavioral Sciences & Health Services Research Award
5. Statement on the findings of the Womens Health Study
6. Bone density returns when teens stop using Depo Provera, Group Health study finds
7. Mailman School of Public Health researchers develop infectious disease diagnostic tool
8. Study naming hospitals in top 5% for clinical quality released by HealthGrades
9. RelayHealth selected by Columbia University to link doctors and patients online
10. Health report-card fears make doctors forgo potential life-saving heart treatment
11. Healthy patients with abdominal lymph nodes seen on CT do not need follow-up imaging

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Health initiatives can help peace building the Middle East

(Date:12/10/2013)... Urban Digital Magazine launches 360° multimedia ... launched its newly developed photo-sharing app, which provides a ... Cynthia Bailey at bar One in Atlanta on Monday, ... tagged with a branded hashtag as well as engages ... unique experience directly on their mobile device. , “Our ...
(Date:12/10/2013)... The top 7 anti-aging foods for people over ... Joel Marion provides information foods that are loaded with the ... can turn back the clock by following the anti-aging recommendations ... The new article posted on Health News Wires details 7 ... designed to support healthy hair and skin and protect ...
(Date:12/10/2013)... Rankingbyseo.com, one of the fastest growing ... SEO packages . The company has announced these ... Now, the Basic SEO package will cost $225; the ... cost $799; and the Enterprise package will cost $1499. ... research on the current marketing trend in online business ...
(Date:12/10/2013)... Plano, TX & Pleasanton, CA (PRWEB) December 10, 2013 ... groups and other professional providers continue to lose revenue ... the low focus hospitals put toward 1500 billing as ... of most physician billing systems. The problem of revenue ... hospitals accelerated acquisition of physician practices, making the need ...
(Date:12/10/2013)... Dr. Daniel T. Morof of Cherry Hill Dental Center ... finally achieve a healthy, permanent smile. By providing dental implants ... who rely on dentures as a result of tooth loss, ... smile. , “Everybody deserves a wonderful smile, and they ... said Dr. Daniel Morof, dental implants dentist in Garden City, ...
Breaking Medicine News(10 mins):Health News:Rolling Out Releases Photo-Sharing App with Cynthia Bailey During Cover Party Multimedia Platform 2Health News:Top 7 Anti-Aging Foods For People Over 40 Article Released By Health News Wires 2Health News:Rankingbyseo.com Announced Changes in Its SEO Packages 2Health News:GAFFEY Healthcare Announces Next Generation Professional Billing Solution 2Health News:Garden City, MI Cosmetic Dentist Dr. Daniel T. Morof Introduces Dental Implants as Best Alternative for Denture Wearers 2
(Date:12/10/2013)... growth in the United States will continue in ... executives in their December 2013 Semiannual Economic Forecast. ... recovery that began in mid-2009, as indicated in ... ® . The manufacturing sector is optimistic about ... in 16 manufacturing industries, and the non-manufacturing sector ...
(Date:12/10/2013)... 10, 2013   Upsher-Smith Laboratories, Inc. ... 1 data showing that USL255 (extended-release topiramate) may ... difficulty swallowing whole capsules or tablets.  Additionally, simulations ... a return to steady-state topiramate levels within one ... up to 18 hours, the risk of dropping ...
(Date:12/10/2013)... YORK, Dec. 10, 2013 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p01374859/Global-Carotenoids-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Synthetic_Dye_and_Pigment This report ... both US$ Million and Tons by the ... Annatto, Capsanthin, and Other Carotenoids. The major ...
Breaking Medicine Technology:Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 2Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 3Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 4Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 5Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 6Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 7Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 8Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 9Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 10Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 11Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 12Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 13Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 14Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 15Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 16Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 17Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 18Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 19Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 20Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 21Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 22Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 23Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 24Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 25Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 26Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 27Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 28Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 29Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 30Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 31Economic Growth Continues In 2014; Manufacturing Growth Expected in 2014; Revenue to Increase 4.4%; Capital Expenditures to Increase 8.0%; Capacity Utilization Currently at 80.3%; Non-Manufacturing Growth Projected in 2014; Revenue to Increase 3.6%; 32Upsher-Smith Presents New Data On The PK Equivalence Of USL255 (Extended-Release Topiramate) When Sprinkled On Food Or Swallowed Intact 2Upsher-Smith Presents New Data On The PK Equivalence Of USL255 (Extended-Release Topiramate) When Sprinkled On Food Or Swallowed Intact 3Upsher-Smith Presents New Data On The PK Equivalence Of USL255 (Extended-Release Topiramate) When Sprinkled On Food Or Swallowed Intact 4Global Carotenoids Industry 2
Cached News: